GENE

GENE Company Financials

$0.37
*  
0.0199
5.68%
Get GENE Alerts
*Delayed - data as of Dec. 19, 2014  -  Find a broker to begin trading GENE now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks


Annual Income Statement (values in 000's) Get Quarterly Data

Period Ending: Trend 6/30/2014 6/30/2013 6/30/2012 6/30/2011
Total Revenue
$4,308 $3,091 $3,784 $4,919
Cost of Revenue
$1,735 $1,781 $1,997 $2,179
Gross Profit
$2,573 $1,311 $1,786 $2,741
Operating Expenses
Research and Development
$3,113 $3,169 $4,130 $4,690
Sales, General and Admin.
$8,088 $6,263 $8,145 ($3,285)
Non-Recurring Items
$0 $0 $0 $0
Other Operating Items
$0 $0 $0 $0
Operating Income
($8,627) ($8,122) ($10,489) $1,336
Add'l income/expense items
$107 $0 $5,241 ($306)
Earnings Before Interest and Tax
($8,863) ($8,522) ($5,383) $1,053
Interest Expense
$702 $36 $46 $88
Earnings Before Tax
($9,565) ($8,558) ($5,430) $965
Income Tax
$0 $0 $0 $0
Minority Interest
$0 $0 $0 $0
Equity Earnings/Loss Unconsolidated Subsidiary
($342) ($400) ($135) $0
Net Income-Cont. Operations
($9,908) ($8,958) ($5,565) $965
Net Income
($9,565) ($8,558) ($5,430) $965
Net Income Applicable to Common Shareholders
($9,565) ($8,558) ($5,430) $965

See also: Company Financials data entry page